Anti-prM antibody as an autoantibody in dengue virus infection

Kao Jean Huang, Yu Tien Cheng, Yee Shin Lin, Jyh Hsiung Huang, Hsiao Sheng Liu, Trai Ming Yeh, Ching Chuan Liu, Huan Yao Lei

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


We have reported that anti-prM antibody is an enhancing antibody that enhances DV infection of non-Fc receptor bearing cells by dual specificity. We identified the epitope recognized by this anti-prM antibody, M3, which is located at the a.a.53-67of the prM protein nearby the prM/M cleavage junction and these anti-M3 antibodies could be detected in dengue patients sera. Surprisingly, this anti-prM antibody not only recognizes the prM protein of dengue virions, but also cross-reacts with epithelial cells, endothelial cells as well as T cells. The binding of anti-prM antibody to endothelial cells was dose-dependent and could be blocked by M3 peptides. Human M3-specific antibodies from dengue patient sera were demonstrated to be able to bind to endothelial cells and mediate ADE infection on K562 cells. Furthermore, the anti-prM antibody will mediate the antibody - dependent cell phagocytosis, leading to the similar severe form of DHF/DSS. In conclusion, anti-prM antibody plays two roles in the pathogenesis of dengue virus infection: to be an enhancing antibody and an autoantibody as well.

Original languageEnglish
Pages (from-to)60-68
Number of pages9
JournalAmerican Journal of Infectious Diseases
Issue number1
Publication statusPublished - 2008

All Science Journal Classification (ASJC) codes

  • Infectious Diseases


Dive into the research topics of 'Anti-prM antibody as an autoantibody in dengue virus infection'. Together they form a unique fingerprint.

Cite this